Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

Delayed Data
As of Jul 06
 +0.47 / +2.21%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 31.00 and a low estimate of 7.00. The median estimate represents a +3.50% increase from the last price of 21.74.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.50%
Growthannually 71.35%


Growthquarterly 81.42%
Growthannually 118.95%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account